CTH and cardiovascular disorder: Hyperhomocysteinemia is a well-known risk factor for cardiovascular disease and leads to downregulation of CBS, CSE, and 3-mercaptopyruvate sulfurtransferase (3-MST) in the kidneys and liver, resulting in decreased H2S plasma levels [57].